We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Ionis Pharmaceuticals announced the appointment of a new member to its board of directors effective immediately – Joan E. Herman, MBA, MS, president and chief executive officer of Herman and Associates.
Halozyme Therapeutics announced the appointment of Bernadette Connaughton to its board of directors. Connaughton brings more than 30 years of global strategic, commercial and biopharmaceutical industry expertise to the board.